Correlation Between Maccura Biotechnology and Zhejiang Kingland

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Maccura Biotechnology and Zhejiang Kingland at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maccura Biotechnology and Zhejiang Kingland into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Maccura Biotechnology Co and Zhejiang Kingland Pipeline, you can compare the effects of market volatilities on Maccura Biotechnology and Zhejiang Kingland and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maccura Biotechnology with a short position of Zhejiang Kingland. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maccura Biotechnology and Zhejiang Kingland.

Diversification Opportunities for Maccura Biotechnology and Zhejiang Kingland

0.91
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Maccura and Zhejiang is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Maccura Biotechnology Co and Zhejiang Kingland Pipeline in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zhejiang Kingland and Maccura Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maccura Biotechnology Co are associated (or correlated) with Zhejiang Kingland. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zhejiang Kingland has no effect on the direction of Maccura Biotechnology i.e., Maccura Biotechnology and Zhejiang Kingland go up and down completely randomly.

Pair Corralation between Maccura Biotechnology and Zhejiang Kingland

Assuming the 90 days trading horizon Maccura Biotechnology Co is expected to under-perform the Zhejiang Kingland. In addition to that, Maccura Biotechnology is 1.14 times more volatile than Zhejiang Kingland Pipeline. It trades about -0.12 of its total potential returns per unit of risk. Zhejiang Kingland Pipeline is currently generating about -0.07 per unit of volatility. If you would invest  626.00  in Zhejiang Kingland Pipeline on October 22, 2024 and sell it today you would lose (44.00) from holding Zhejiang Kingland Pipeline or give up 7.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Maccura Biotechnology Co  vs.  Zhejiang Kingland Pipeline

 Performance 
       Timeline  
Maccura Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Maccura Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Zhejiang Kingland 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zhejiang Kingland Pipeline has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Maccura Biotechnology and Zhejiang Kingland Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Maccura Biotechnology and Zhejiang Kingland

The main advantage of trading using opposite Maccura Biotechnology and Zhejiang Kingland positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maccura Biotechnology position performs unexpectedly, Zhejiang Kingland can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zhejiang Kingland will offset losses from the drop in Zhejiang Kingland's long position.
The idea behind Maccura Biotechnology Co and Zhejiang Kingland Pipeline pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.